{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:37:20Z","timestamp":1774456640620,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11547-018-0949-5","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T06:48:38Z","timestamp":1540450118000},"page":"132-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fiducial markers implantation for prostate image-guided radiotherapy: a report on the transperineal approach"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-7872","authenticated-orcid":false,"given":"Luigi","family":"De Cicco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bracelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"949_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2016.08.005","volume":"50","author":"B Bari De","year":"2016","unstructured":"De Bari B, Arcangeli S, Ciardo D, Mazzola R, Alongi F, Russi EG, Santoni R, Magrini SM, Jereczek-Fossa BA, on the behalf of the Italian Association of Radiation Oncology (AIRO) (2016) Extreme hypofractionation for early prostate cancer: biology meets technology. Cancer Treat Rev 50:48\u201360. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2016.08.005","journal-title":"Cancer Treat Rev"},{"issue":"1068","key":"949_CR2","doi-asserted-by":"publisher","first-page":"20160296","DOI":"10.1259\/bjr.20160296","volume":"89","author":"AG O\u2019Neill","year":"2016","unstructured":"O\u2019Neill AG, Jain S, Hounsell AR, O\u2019Sullivan JM (2016) Fiducial marker guided prostate radiotherapy: a review. Br J Radiol 89(1068):20160296","journal-title":"Br J Radiol"},{"issue":"4","key":"949_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1754-9485.2011.02278.x","volume":"55","author":"S Brown","year":"2011","unstructured":"Brown S, Lehman M, Ferrari-Anderson J, Glyde A, Burmeister E, Nicol D (2011) Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement. J Med Imaging Radiat Oncol 55(4):417\u2013424. \n                    https:\/\/doi.org\/10.1111\/j.1754-9485.2011.02278.x","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"949_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","volume":"11","author":"FM Wagenlehner","year":"2014","unstructured":"Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014) Reducing infection rates after prostate biopsy. Nat Rev Urol 11(2):80\u201386","journal-title":"Nat Rev Urol"},{"issue":"3","key":"949_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.clon.2015.09.008","volume":"28","author":"DR Henderson","year":"2016","unstructured":"Henderson DR, Murray JR, Tree AC, Riley U, Rosenfelder NA, Murray D, Khoo VS, van As NJ (2016) Targeted antibiotic prophylaxis for transrectal fiducial marker insertion for prostate radiotherapy. Clin Oncol (R Coll Radiol) 28(3):226\u2013227. \n                    https:\/\/doi.org\/10.1016\/j.clon.2015.09.008","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"949_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ijrobp.2007.04.009","volume":"69","author":"JF Langenhuijsen","year":"2007","unstructured":"Langenhuijsen JF, van Lin EN, Kiemeney LA, van der Vight LP, McColl GM, Visser AG, Witjes JA (2007) Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys 69(3):671","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"949_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13014-015-0347-2","volume":"10","author":"J Loh","year":"2015","unstructured":"Loh J, Baker K, Sridharan S, Greer P, Wratten C, Capp A, Gallagher S, Martin J (2015) Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks? Radiat Oncol 10:38. \n                    https:\/\/doi.org\/10.1186\/s13014-015-0347-2","journal-title":"Radiat Oncol"},{"issue":"4","key":"949_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jmrs.122","volume":"62","author":"A Saad","year":"2015","unstructured":"Saad A, Goldstein J, Lawrence YR, Weiss I, Saad R, Spieler B, Symon Z (2015) Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications. J Med Radiat Sci 62(4):261\u2013266. \n                    https:\/\/doi.org\/10.1002\/jmrs.122","journal-title":"J Med Radiat Sci"},{"issue":"1","key":"949_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2010.02.027","volume":"96","author":"MR Moman","year":"2010","unstructured":"Moman MR, van der Heide UA, Kotte AN, van Moorselaar RJ, Bol GH, Franken SP, van Vulpen M (2010) Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life. Radiother Oncol 96(1):38\u201342. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2010.02.027","journal-title":"Radiother Oncol"},{"issue":"8","key":"949_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.canrad.2016.07.097","volume":"20","author":"A Cordoba","year":"2016","unstructured":"Cordoba A, Pasquier D, Nickers P, Lacornerie T, Lartigau \u00c9 (2016) Intraprostatic fiducials in stereotactic radiotherapy for prostate cancer. Cancer Radiother 20(8):815\u2013819. \n                    https:\/\/doi.org\/10.1016\/j.canrad.2016.07.097","journal-title":"Cancer Radiother"},{"issue":"6","key":"949_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00066-017-1104-2","volume":"193","author":"K Jorgo","year":"2017","unstructured":"Jorgo K, \u00c1goston P, Major T, Tak\u00e1csi-Nagy Z, Polg\u00e1r C (2017) Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer. Strahlenther Onkol 193(6):452\u2013458. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1104-2","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"949_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.radonc.2004.08.007","volume":"73","author":"AM Henry","year":"2004","unstructured":"Henry AM, Wilkinson C, Wylie JP, Logue JP, Price P, Khoo VS (2004) Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol 73(1):57\u201359","journal-title":"Radiother Oncol"},{"issue":"10","key":"949_CR13","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1118\/1.1604491","volume":"30","author":"M Stutz","year":"2003","unstructured":"Stutz M, Petrikas J, Raslowsky M, Lee P, Gurel M, Moran B (2003) Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and urine straining post implant. Med Phys 30(10):2695\u20132698","journal-title":"Med Phys"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-018-0949-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-018-0949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-018-0949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:34:36Z","timestamp":1572021276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-018-0949-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["949"],"URL":"https:\/\/doi.org\/10.1007\/s11547-018-0949-5","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a retrospective study. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}